110 related articles for article (PubMed ID: 6936384)
21. Pyridine nucleotide transhydrogenase in normal human and leukemic leukocytes.
Evans AE; Kaplan NO
J Clin Invest; 1966 Aug; 45(8):1268-72. PubMed ID: 5223965
[No Abstract] [Full Text] [Related]
22. Biosynthesis of heme in leukemic leukocytes.
Walters TR; Welland FH; Gribble TJ; Schwartz HC
Cancer; 1967 Jul; 20(7):1117-23. PubMed ID: 5229723
[No Abstract] [Full Text] [Related]
23. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
24. Comparison of oncogene expression in human normal bone marrow and leukemia.
Evinger-Hodges MJ; Blick M; Bresser J; Dicke KA
Ann N Y Acad Sci; 1987; 511():284-91. PubMed ID: 3326467
[No Abstract] [Full Text] [Related]
25. Bone marrow lipofuscin in a patient with acute myeloid leukaemia and extensive marrow necrosis.
Giannoutsos I; Rosenfeld D
Br J Haematol; 2007 Jul; 138(2):129. PubMed ID: 17489981
[No Abstract] [Full Text] [Related]
26. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
Iversen PO; Wiig H
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
[TBL] [Abstract][Full Text] [Related]
27. [Cytochemistry of chronic myeloid leukemia].
Tikhonova LIu
Ter Arkh; 1981; 53(9):28-31. PubMed ID: 6946603
[No Abstract] [Full Text] [Related]
28. Anaerobic glycolysis in normal and leukemic bone-marrow leukocytes. Effect of methyl-glyoxal-bis-guanylhydrazone dihydrochloride.
Kolmeier KH; Silverstein MN; Fleisher GA
Cancer; 1966 Sep; 19(9):1195-9. PubMed ID: 5223469
[No Abstract] [Full Text] [Related]
29. [In vivo concentrations of an antimitotic, daunorubicin, in peripheral and bone marrow human leukemia cells].
Faucon G; Trillet V; Lang J; Lakhal M; Timour Chah Q
Bull Acad Natl Med; 1985 Oct; 169(7):1045-52. PubMed ID: 3914322
[No Abstract] [Full Text] [Related]
30. [Granulocyte chalone normally and in acute myeloblastic and chronic myeloid leukemias].
Bala IuM; Kovalevskaia NP
Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):14-8. PubMed ID: 6459577
[No Abstract] [Full Text] [Related]
31. Fate of 14C-glucan in normal and acute myelogenous leukemic rats.
Gilbert K; Chu F; Jones E; Di Luzio NR
J Reticuloendothel Soc; 1977 Oct; 22(4):319-27. PubMed ID: 270588
[No Abstract] [Full Text] [Related]
32. [Value of cytochemical study of bone marrow in predicting the course of a blast crisis in chronic myeloid leukemia patients].
Vaiuta NP; Kheĭfets LM
Ter Arkh; 1980; 52(9):40-2. PubMed ID: 6933711
[No Abstract] [Full Text] [Related]
33. Myeloid cell actinomycin binding in human myeloid leukaemia.
Pileri A; Masera P; Garbarino G; Hulin N
Acta Haematol; 1974; 51(1):1-8. PubMed ID: 4217070
[No Abstract] [Full Text] [Related]
34. [Hypervitaminemia B-12 in leukemia and myeloproliferative syndromes].
Zittoun J; Zittoun R; Guernet M; Bilski-Pasquier G; Bousser J
Rev Fr Etud Clin Biol; 1968; 13(7):684-94. PubMed ID: 5248357
[No Abstract] [Full Text] [Related]
35. Isolation of inhibitor of 3H-thymidine incorporation from normal leucocyte conditioned medium.
Rao SG; Bhisey AN; Advani SH
Indian J Exp Biol; 1978 Oct; 16(10):1032-4. PubMed ID: 285922
[No Abstract] [Full Text] [Related]
36. Spontaneous interferon production in cultures of a cell line from a human myeloblastic leukemia.
Deinhardt F; Burnside J
J Natl Cancer Inst; 1967 Oct; 39(4):681-3. PubMed ID: 18623929
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
38. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
39. 1-beta-D-arabinofuranosylcytosine (ara-C) deamination in human leukemic myeloblasts is not a mechanism of resistance to ara-C therapy.
Harris AL
Cancer Res; 1981 Jul; 41(7):2977-9. PubMed ID: 6941850
[No Abstract] [Full Text] [Related]
40. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
